eXoZymes Inc. (EXOZ)
Nasdaq: EXOZ · Biological Products, (No Diagnostic Substances) · Monrovia, CA · filing with the SEC since 2024
Who owns eXoZymes Inc.
As filed with the SECHolders of 5% or more
0
No Schedule 13D or 13G naming this company is on file.
Directors and officers
11
report now, of 12 people on the record since 2024. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 0 named at left.
Holders of 5% or moreshare of the class, as filed
No holder of 5% or more is on file in a Schedule 13D or 13G naming this company.
What EXOZ reports owning in othersstakes of 5% or more, and other ties
1 subsidiary in 1 country, from the list filed with the 10-K filed Mar 31, 2025.
Insider tradesForm 4
3sales
5purchases
0sales on a scheduled plan
2people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 26, 2025 to Oct 26, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
2026 runs to Oct 26, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 13 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Heltzen Michael | Chief Executive Officer | 0 | $0 | 0 | 5 | $0 |
| Perriman Damien Alan | Chief Commercial Officer | 1 | $0 | 0 | 0 | $0 |
| Korman Tyler Paz | Chief Scientific Officer | 2 | $0 | 0 | 0 | $0 |